Cell Therapy Catapult Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Cell Therapy Catapult Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11239
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cell Therapy Catapult Ltd (Catapult) is a provider of cell and gene therapy life cycle solutions. The company offers services such as industrialization, manufacturing, regulatory, health economics and market access, non-clinical safety and clinical operations. Its health economics and market access provide pricing and reimbursement and commercial management for gene therapies and other types of therapies. Catapult provides technology platform and clinical trials. The company also offers reimbursement and adoption of therapies. It partners healthcare sector and clinical researchers. Catapult is headquartered in London, the UK.

Cell Therapy Catapult Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Cell Therapy Catapult Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Asymptote Enters into Licensing Agreement with Cell and Gene Therapy Catapult 13
Cell Therapy Catapult to Enter into Agreement with Japanese Society for Regenerative Medicine 14
Cell Therapy Catapult Enters into Agreement with Freeline Therapeutics 15
Cell Therapy Catapult and CombiGene Sign Agreement for CG01 16
Oxford BioMedica Enters into Agreement with Cell Therapy Catapult, Stratophase and Synthace 17
Cell Therapy Catapult Enters into Agreement with CRC for Cell Therapy Manufacturing 18
Cell Therapy Catapult Enters into partnership with Cooperative Research Centre for Cell Therapy Manufacturing 19
Cell Therapy Catapult Forms Joint Venture with University of Aberdeen 20
Synpromics Enters into Agreement with Cell Therapy Catapult 21
Cell Therapy Catapult Enters into Joint venture Agreement with University of Birmingham and Cancer Research Technology 22
Asterias Biotherapeutics Enters into Agreement with Cell Therapy Catapult 23
Cell Therapy Catapult Enters into Agreement with Asymptote 24
Cell Therapy Catapult, Plasticell and University of Oxford Enter into Agreement 25
TAP Biosystems Enters into Agreement with Cell Therapy Catapult 26
Cell Therapy Catapult, Azellon, University of Liverpool and NHS Blood and Transplant Enter into Agreement 27
Cell Therapy Catapult Enters into Agreement with Athersys 28
Cell Therapy Catapult Enters into Research Agreement with TrakCel 29
Cell Therapy Catapult Forms Catapult Therapy TCR with UCL Business and Imperial Innovations 30
ReNeuron Enters Into Co-Development Agreement With Cell Therapy Catapult 31
Licensing Agreements 32
Cell Therapy Catapult Enters into Licensing Agreement with iPS Academia Japan 32
Acquisition 33
Cell Medica Acquires Catapult Therapy TCR from Cell Therapy Catapult 33
Cell Therapy Catapult Ltd – Key Competitors 34
Cell Therapy Catapult Ltd – Key Employees 35
Cell Therapy Catapult Ltd – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Joint Venture 36
Recent Developments 37
Corporate Communications 37
Oct 18, 2018: CGT Catapult names Three New Board Members 37
Jun 06, 2018: Cell and Gene Therapy Catapult Appoints Dr Jonathan Appleby As Chief Scientific Officer 39
Other Significant Developments 40
May 16, 2018: CGT Catapult announces major UK investment in skills and capabilities 40
Feb 28, 2018: CGT Catapult holds inaugural Seminar Series 41
Jan 08, 2018: Adaptimmune Announces Two Manufacturing Achievements on Its way to Become the First Fully Integrated TCR T-cell Therapy Company 42
Nov 13, 2017: Cell and Gene Therapy Catapult research highlights the UK’s growing global leadership in innovative cell and gene therapy industry 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cell Therapy Catapult Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Cell Therapy Catapult Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Asymptote Enters into Licensing Agreement with Cell and Gene Therapy Catapult 13
Cell Therapy Catapult to Enter into Agreement with Japanese Society for Regenerative Medicine 14
Cell Therapy Catapult Enters into Agreement with Freeline Therapeutics 15
Cell Therapy Catapult and CombiGene Sign Agreement for CG01 16
Oxford BioMedica Enters into Agreement with Cell Therapy Catapult, Stratophase and Synthace 17
Cell Therapy Catapult Enters into Agreement with CRC for Cell Therapy Manufacturing 18
Cell Therapy Catapult Enters into partnership with Cooperative Research Centre for Cell Therapy Manufacturing 19
Cell Therapy Catapult Forms Joint Venture with University of Aberdeen 20
Synpromics Enters into Agreement with Cell Therapy Catapult 21
Cell Therapy Catapult Enters into Joint venture Agreement with University of Birmingham and Cancer Research Technology 22
Asterias Biotherapeutics Enters into Agreement with Cell Therapy Catapult 23
Cell Therapy Catapult Enters into Agreement with Asymptote 24
Cell Therapy Catapult, Plasticell and University of Oxford Enter into Agreement 25
TAP Biosystems Enters into Agreement with Cell Therapy Catapult 26
Cell Therapy Catapult, Azellon, University of Liverpool and NHS Blood and Transplant Enter into Agreement 27
Cell Therapy Catapult Enters into Agreement with Athersys 28
Cell Therapy Catapult Enters into Research Agreement with TrakCel 29
Cell Therapy Catapult Forms Catapult Therapy TCR with UCL Business and Imperial Innovations 30
ReNeuron Enters Into Co-Development Agreement With Cell Therapy Catapult 31
Cell Therapy Catapult Enters into Licensing Agreement with iPS Academia Japan 32
Cell Medica Acquires Catapult Therapy TCR from Cell Therapy Catapult 33
Cell Therapy Catapult Ltd, Key Competitors 34
Cell Therapy Catapult Ltd, Key Employees 35
Cell Therapy Catapult Ltd, Subsidiaries 36
Cell Therapy Catapult Ltd, Joint Venture 36

List of Figures
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cell Therapy Catapult Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Cell Therapy Catapult Ltd, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Cell Therapy Catapult Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Volkswagen Financial Services AG:戦略・SWOT・企業財務分析
    Volkswagen Financial Services AG - Strategy, SWOT and Corporate Finance Report Summary Volkswagen Financial Services AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Lakewood-Amedex Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lakewood-Amedex Inc (Lakewood-Amedex) is a clinical-stage pharmaceutical company with focus on the development of antimicrobial and antifungal medicines to address unmet needs in the treatment of serious infectious diseases. The company develops anti-infective products such as anti-bacterial …
  • Topcon Corp (7732)-医療機器分野:企業M&A・提携分析
    Summary Topcon Corp (Topcon) is a medical device company that offers positioning and smart infrastructure and eye care products. The company provides positioning and smart infrastructure products which include TOCON and SOKKIA products. Topcon offers GNSS, total station, 3D scanner, machine control, …
  • Nelnet, Inc.:企業のM&A・事業提携・投資動向
    Nelnet, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nelnet, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • MiMedx Group Inc – Product Pipeline Analysis, 2018 Uate
    Summary MiMedx Group Inc (MiMedx) is a biopharmaceutical company that develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary pur …
  • Swire Pacific Ltd:戦略・SWOT・企業財務分析
    Swire Pacific Ltd - Strategy, SWOT and Corporate Finance Report Summary Swire Pacific Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Kuraray Co Ltd (3405):企業の財務・戦略的SWOT分析
    Kuraray Co Ltd (3405) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • athenahealth Inc (ATHN):製薬・医療:M&Aディール及び事業提携情報
    Summary athenahealth Inc (athenahealth) is a provider of cloud-based business services and mobile applications for medical groups and health system. The company offers network-enabled services for revenue cycle management and medical billing, electronic health records (EHR), patient engagement, popu …
  • Shionogi Inc:企業の戦略的SWOT分析
    Shionogi Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • RainDance Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary RainDance Technologies Inc (RDT), a subsidiary of Bio-Rad Laboratories Inc is a developer of genomic tools for non-invasive liquid biopsy applications. The company’s products include RainDrop Plus, a digital PCR system that provides picoliter droplets for multiplex detection of HIV and DNA; …
  • TapImmune Inc (TPIV):企業の財務・戦略的SWOT分析
    Summary TapImmune Inc (TapImmune) is a clinical-stage immuno-oncology company focus on the development of innovative peptide, gene-based immunotherapeutics and vaccines for the treatment of cancer and metastatic disease. The company’s pipeline products include TPIV 200, which is intended for the tre …
  • Power Assets Holdings Ltd (6):電力:M&Aディール及び事業提携情報
    Summary Power Assets Holdings Limited (Power Assets) a subsidiary of CK Infrastructure Holdings Limited, is an investment holding company. The company through its subsidiaries, joint ventures, and affiliates, invests in power and utility-related businesses. The company has interests in electricity g …
  • Fuller, Smith & Turner Plc:企業の戦略・SWOT・財務情報
    Fuller, Smith & Turner Plc - Strategy, SWOT and Corporate Finance Report Summary Fuller, Smith & Turner Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Siemens Healthineers.:企業のM&A・事業提携・投資動向
    Siemens Healthineers. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Siemens Healthineers. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Biolife Solutions Inc (BLFS):企業の財務・戦略的SWOT分析
    Summary Biolife Solutions Inc (BioLife Solutions) is a developer, manufacturer and supplier of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media for cells and tissues. The company offers serum-free and protein-free solutions, which are formulated to red …
  • IMV Inc (IMV):企業の財務・戦略的SWOT分析
    Summary IMV Inc (IMV), formerly Immunovaccine Inc, is a biopharmaceutical company that develops immunotherapies and vaccines to treat cancer and infectious diseases. The company is investigating its pipeline candidates DPX-Survivac against ovarian, bladder, liver, non-small cell lung cancer and diff …
  • Handelsbanken Great Britain
    Handelsbanken Great Britain - Strategy, SWOT and Corporate Finance Report Summary Handelsbanken Great Britain - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • H-E-B Grocery Company L.P.:企業の戦略・SWOT・財務情報
    H-E-B Grocery Company L.P. - Strategy, SWOT and Corporate Finance Report Summary H-E-B Grocery Company L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Mitsubishi Electric Corporation:企業の戦略・SWOT・財務情報
    Mitsubishi Electric Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Electric Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Covestro AG (1COV):企業の財務・戦略的SWOT分析
    Covestro AG (1COV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆